Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor type 1A (5-HT1A receptor) is a G protein-coupled receptor (GPCR) that binds serotonin (5-hydroxytryptamine, 5-HT) and is encoded by the HTR1A gene[1][6]. It is the most widely distributed serotonin receptor in the brain, with high densities in the cerebral cortex, hippocampus, septum, amygdala, and raphe nuclei. The receptor functions as both a somatodendritic autoreceptor on serotonergic neurons—regulating serotonin release—and as a postsynaptic heteroreceptor on other neuron types, modulating mood, anxiety, cognition, and neuroendocrine function. Alterations in its expression or function have been directly linked to major depressive disorder, anxiety disorders, and other psychiatric conditions. Clinically, it is targeted by a range of drugs, including partial agonists (anxiolytics and antidepressants) and antagonists, and its gene polymorphisms serve as biomarkers for disease risk and therapeutic response[1][2][3][4][6].
Agonist binding induces Gi protein coupling, reducing neuronal firing and cAMP production Partial agonists modulate receptor activity, resulting in antidepressant or anxiolytic effects Antagonists block serotonin binding, affecting serotonergic tone Regulation of presynaptic autoreceptors and postsynaptic heteroreceptors[1][3][4]
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin receptor type 1A (5-HT1A receptor).